267 Metal cation-transporting ATPase, ATP-binding domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 28 | 9.0 | 3.11× | q < 0.0001 | |
| Homogeneous metal compounds | 19 | 16.0 | 1.19× | q = 0.38 | |
| Homogeneous non-metal compounds | 1 | 7.0 | 0.14× | q = 0.02 | |
| Organic acids and derivatives | 0 | 5.0 | 0 | q = 0.01 | |
| Organic oxygen compounds | 0 | 6.5 | 0 | q = 3.3e-3 | |
| Organoheterocyclic compounds | 0 | 5.0 | 0 | q = 0.01 | |
| Mixed metal/non-metal compounds | 13 | 0.7 | 19× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 51 |
| DB16833 | ADP | Adenosine disphosphate | 27 |
| DB00171 | ATP | ATP | 16 |
| DB04444 | ALF | Tetrafluoroaluminate Ion | 13 |
| DB02524 | 128 | 2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate) | 7 |
| DB00228 | — | — | 2 |
| DB06157 | — | — | 2 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB00213 | — | — | 1 |
| DB00338 | — | — | 1 |
| DB00390 | — | Digoxin | 1 |
| DB00448 | — | — | 1 |
| DB00511 | — | — | 1 |
| DB00736 | — | — | 1 |
| DB00753 | — | Isoflurane | 1 |
| DB00774 | — | Hydroflumethiazide | 1 |
| DB00903 | — | Etacrynic acid | 1 |
| DB01021 | — | — | 1 |
| DB01028 | — | — | 1 |
| DB01078 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 120 |
| ACP | PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER | 61 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 42 |
| BEF | BERYLLIUM TRIFLUORIDE ION | 31 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 23 |
| ALF | TETRAFLUOROALUMINATE ION | 16 |
| RBmetal | RUBIDIUM ION | 8 |
| 128 | SPIRO(2,4,6-TRINITROBENZENE[1,2A]-2O',3O'-METHYLENE-ADENINE-TRIPHOSPHATE | 7 |
| TM1 | 2',3'-O-[(1r)-2,4,6-trinitrocyclohexa-2,5-diene-1,1-diyl]adenosine 5'-(dihydrogen phosphate) | 6 |
| MF4 | TETRAFLUOROMAGNESATE(2-) | 4 |
| A99 | 5'-O-[(S)-hydroxy{[(R)-hydroxy({(S)-hydroxy[(1S)-1-(2-nitrophenyl)ethoxy]phosphoryl}oxy)phosphoryl]oxy}phosphoryl]adenosine | 3 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 3 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 3 |
| CAmetal | CALCIUM ION | 3 |
| VN4 | oxido(dioxo)vanadium | 3 |
| DL5 | Spiro(2,4,6-trinitrobenzene[1,2a]-O2',O3'-methylene-adenosine (beta,gamma-methylene)triphosphate | 2 |
| IOD | IODIDE ION | 2 |
| 12D | 2',3'-O-[(1R,6R)-2,4,6-trinitrocyclohexa-2,4-diene-1,1-diyl]adenosine 5'-(trihydrogen diphosphate) | 1 |
| AMP | ADENOSINE MONOPHOSPHATE | 1 |
| AN2 | AMP PHOSPHORAMIDATE | 1 |